Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
January 1, 1985
Chromogenic peptide substrate assays for determining components of the plasma kallikrein system
M J Gallimore
Advances in Experimental Medicine and Biology
|
January 1, 1983
Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease
M J Gallimore
Thrombosis Research
|
April 1, 1978
Inter-alpha-antiplasmin: its distinction from antiactivator
M J Gallimore
Thrombosis Research
|
January 1, 1980
Inhibition of the amidolytic activity of urokinase by human plasma
M J Gallimore
Journal of Thrombosis and Haemostasis : JTH
|
January 18, 2006
More on: Discovery of alpha2-plasmin inhibitor and its congenital deficiency
M J Gallimore
British Journal of Haematology
|
October 1, 1975
Serum inhibitors in fibrinolysis
M J Gallimore
Advances in Experimental Medicine and Biology
|
January 1, 1986
Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma
P Friberger, M J Gallimore
Blood Reviews
|
June 1, 1991
Chromogenic peptide substrate assays and their clinical applications
M J Gallimore, P Friberger
Thrombosis Research
|
August 1, 1977
Further evidence for the presence of two plasma inhibitors of fibrinolysis distinct from alpha2-macroglobulin
M J Gallimore, U Hedner
Thrombosis Research
|
February 1, 1982
Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma
M J Gallimore, P Friberger
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|
January 1, 1985
Chromogenic peptide substrate assays for determining components of the plasma kallikrein system
M J Gallimore
Advances in Experimental Medicine and Biology
|
January 1, 1983
Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease
M J Gallimore
Thrombosis Research
|
April 1, 1978
Inter-alpha-antiplasmin: its distinction from antiactivator
M J Gallimore
Thrombosis Research
|
January 1, 1980
Inhibition of the amidolytic activity of urokinase by human plasma
M J Gallimore
Journal of Thrombosis and Haemostasis : JTH
|
January 18, 2006
More on: Discovery of alpha2-plasmin inhibitor and its congenital deficiency
M J Gallimore
British Journal of Haematology
|
October 1, 1975
Serum inhibitors in fibrinolysis
M J Gallimore
Advances in Experimental Medicine and Biology
|
January 1, 1986
Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma
P Friberger, M J Gallimore
Blood Reviews
|
June 1, 1991
Chromogenic peptide substrate assays and their clinical applications
M J Gallimore, P Friberger
Thrombosis Research
|
August 1, 1977
Further evidence for the presence of two plasma inhibitors of fibrinolysis distinct from alpha2-macroglobulin
M J Gallimore, U Hedner
Thrombosis Research
|
February 1, 1982
Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma
M J Gallimore, P Friberger
Page
of 7